Couly Simon, Yasui Yuko, Grammatikakis Ioannis, Kimura Yuriko, Hinkle Josh, Gomez Juan, Wu Hsiang-En, Paritosh Ghosh, Lal Ashish, Michaelides Michael, Harvey Brandon, Su Tsung-Ping
Cellular Pathobiology Section, Integrative Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, NIH/DHHS, Suite 3512, 333 Cassell Drive, Baltimore, MD, 21224, USA.
Regulatory RNAs and Cancer Section, Genetics Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), Bethesda, MD 20892, USA.
bioRxiv. 2025 Jul 31:2025.07.28.667250. doi: 10.1101/2025.07.28.667250.
Sigma-1 receptor (S1R) is a Ca sensitive, ligand-operated receptor chaperone protein present on the endoplasmic reticulum (ER) membrane and more specifically at the mitochondria-associated ER membrane (MAM). Upon activation by ER calcium depletion or ligand binding, S1R can increase calcium efflux from the ER into the mitochondria by chaperoning IP3 receptor type3 (Ip3R3). Mitochondrial metabolism has an intricate relationship with glycolysis. Despite S1R affecting mitochondria, the relevance of S1R to glycolysis and its impact on the overall cellular energy metabolism is not known. This study utilizes wild-type (Wt) and S1R knockout (S1R KO) Neuro2a (N2a) cells and Wt and S1R KO mice for primary culture of cortical neurons studies and longitudinal imaging. In this manuscript we describe the fundamental functions of S1R on glycolysis, mitochondrial activity and NAD/NADH metabolism, keystone coenzymes essential for glycolysis and for mitochondrial activity. Both N2a cells and cortical neurons lacking S1R had reduced glycolytic activity, and increased mitochondria complex I protein GRIM19 but no change in mitochondrial oxygen consumption. Furthermore, we observed an increased NAD/NADH ratio in S1R KO condition. Positron emission tomography revealed decreased [F]fluorodeoxyglucose brain uptake in S1R KO mice. We observed that knocking down GRIM19 in S1R KO condition rescued the glycolysis deficit. Altogether, these data show for the first time that S1R modulates glycolysis and NAD metabolism in various neuronal systems. This new insight on the S1R function may lead to new therapeutic applications of S1R ligands where compromised glycolysis and cellular NAD+/NADH ratios occur such as aging and neurodegeneration.
西格玛-1受体(S1R)是一种对钙敏感的、配体门控的受体伴侣蛋白,存在于内质网(ER)膜上,更具体地说,存在于线粒体相关内质网膜(MAM)上。在受到内质网钙耗竭或配体结合激活后,S1R可以通过陪伴肌醇三磷酸受体3型(Ip3R3)增加钙从内质网外流进入线粒体。线粒体代谢与糖酵解有着复杂的关系。尽管S1R影响线粒体,但S1R与糖酵解的相关性及其对整体细胞能量代谢的影响尚不清楚。本研究利用野生型(Wt)和S1R基因敲除(S1R KO)的Neuro2a(N2a)细胞以及Wt和S1R KO小鼠进行皮质神经元原代培养研究和纵向成像。在本论文中,我们描述了S1R在糖酵解、线粒体活性和NAD/NADH代谢方面的基本功能,NAD/NADH是糖酵解和线粒体活性所必需的关键辅酶。缺乏S1R的N2a细胞和皮质神经元均具有降低的糖酵解活性,线粒体复合物I蛋白GRIM19增加,但线粒体氧消耗无变化。此外,我们观察到在S1R基因敲除条件下NAD/NADH比值增加。正电子发射断层扫描显示S1R基因敲除小鼠脑内[F]氟脱氧葡萄糖摄取减少。我们观察到在S1R基因敲除条件下敲低GRIM19可挽救糖酵解缺陷。总之,这些数据首次表明S1R在各种神经元系统中调节糖酵解和NAD代谢。对S1R功能的这一新见解可能会导致S1R配体在糖酵解和细胞NAD+/NADH比值受损的情况下,如衰老和神经退行性变,有新的治疗应用。